蔡宏伟, 李砚泓, 张子豹, 邓亚中. 药物临床试验数据互联互通的应用及展望J. 药学学报, 2015,50(11): 1415-1419.
引用本文: 蔡宏伟, 李砚泓, 张子豹, 邓亚中. 药物临床试验数据互联互通的应用及展望J. 药学学报, 2015,50(11): 1415-1419.
CAI Hong-wei, LI Yan-hong, ZHANG Zi-bao, DENG Ya-zhong. The significance, development and prospects of healthcare data integration in new drug clinical trialsJ. Acta Pharmaceutica Sinica, 2015,50(11): 1415-1419.
Citation: CAI Hong-wei, LI Yan-hong, ZHANG Zi-bao, DENG Ya-zhong. The significance, development and prospects of healthcare data integration in new drug clinical trialsJ. Acta Pharmaceutica Sinica, 2015,50(11): 1415-1419.

药物临床试验数据互联互通的应用及展望

The significance, development and prospects of healthcare data integration in new drug clinical trials

  • 摘要: 随着医院信息系统, 尤其是电子病历系统在医院的部署和普及, 大量日常诊疗数据被存储在医院信息系统中, 为药物临床试验提供了潜在的数据来源。本文综述了数据互联互通为药物临床试验带来的机遇、实际应用中的障碍, 以及国内外该领域的最新进展。

     

    Abstract: With the deployment of electronic medical records systems, more and more routine clinical data are recorded electronically, which become a potential data source for new drug clinical trials. In this paper, we summarized the opportunities, challenges, obstacles and the latest development in this field.

     

/

返回文章
返回